Embedded Files
Increased Success in Having a Child With PGS
Increased Success in Having a Child With PGS
Chromosomal abnormalities that are a major cause of in vitro fertilization (IVF) failure can now be avoided. More than 80% of IVF program failures are caused by chromosomal abnormalities, therefore identification of chromosomal abnormalities before embryo transfer is important in determining IVF success. The solution to solve this problem is pre-implantation genetic screening (PGS). Visit http://www.gender-baby.com/ if you want to join our program.
PGS is the action of chromosome examination on the embryo before embryo transfer or embryo planting into the uterus. A normal embryo consists of a number of cells each of which contains 46 chromosomes, including the x and y chromosomes that are sex chromosomes. If the embryo has a chromosome number of less than or more than 46 then the embryo has a disorder called aneuploidy. The purpose of PGS is to identify aneuploidy embryos so that only the embryos with normal chromosome numbers are reintroduced into the uterus. If you want to ask more about this, you can visit http://www.gender-baby.com/faqs/. Research shows that with PGS the success of the IVF program has increased significantly. In addition to increasing the success of IVF, the advantages of PGS include:
- Reduce the risk of miscarriage.
- Lowered the cost of storing freezing embryos because only the embryos with normal chromosome numbers are kept
- Allows single embryo transfers to reduce the possibility of multiple pregnancies (twins or triplets) which are risky pregnancies
- Eliminate maternal age factor as a factor influencing IVF success (with PGS IVF success rate in older women same as young women)
The presence of In Vitro Fertilization (IVF) or IVF has been accepted as one of the reproductive technologies of pregnant pregnancy that can promise the best possible pregnancy. However, the success of the IVF program is at a relatively not an optimal level. Supported by technological advances in the medical and embryological fields supporting the more optimal embryonic culture system, currently, the success of IVF program is at a fairly good level, ranging from 40%. However, with the best system though, the success rate of IVF program is still very limited. This is related to embryonic chromosomal abnormalities that occupy 80% of the causes of failure of the IVF program. An aneuploidy embryo (having chromosomal abnormalities) cannot develop normally, therefore identification of chromosomal abnormalities before embryo transfer is important in determining IVF success. Visit http://www.gender-baby.com/overview/family-balancing/ to do PGS.
Various researchers and methods were developed to address this problem. One of them is by performing cell biopsy taken from the embryo. This method is a method that can know with certainty whether embryos to be implanted have chromosomal abnormalities or not. Currently, present the latest technology in the form of arrays-Comparative Genomic Hybridization (aCGH) that allows chromosome analysis easier to do. With aCGH, the laboratory can obtain chromosome analysis results from a single cell sample in just a matter of hours (maximum 24 hours).
PGS (Pre-Implantation Genetic Screening) is an act of chromosome examination of the embryo with aCGH technology performed before embryo transfer or embryo planting into the uterus/womb. The purpose of PGS is to identify the aneuploidy embryo so that only the embryo with normal chromosome number is reinvested into in the womb. PGS can increase the success of implantation from 30% to 60-70%.
Contact Us :
Gender Baby
333 S Arroyo Parkway, 3rd Floor, Pasadena, CA 91105
888-976-2254
info@gender-baby.com
Dr Jeffrey Nelson
Website:
http://www.gender-baby.com/faqs/
http://www.gender-baby.com/overview/family-balancing/
External links :
http://www.gender-baby.com/faqs/
Google Sites
Report abuse